Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1231.00
-14.50 (-1.16%) Dr. Reddys Laboratories inform about press release
Date: 19-03-2020Dr. Reddys Laboratories has informed that the company has enclosed a Press Release on March 19 2020 tilted ‘Dr. Reddy's Laboratories announces first-to-market launch of Naloxone Hydrochloride Injection USP, 2 mg/2 mL (1 mg/mL) Singledose Prefilled Syringe in the US Market.’
The above information is a part of company’s filings submitted to BSE.